Ciclosporin,
CsA Neoral,
CsA-Neoral,
CsANeoral,
CyA NOF,
CyA-NOF,
Cyclosporin,
Cyclosporin A,
Cyclosporine,
Cyclosporine A,
Neoral,
OL 27 400,
OL 27-400,
OL 27400,
Sandimmun,
Sandimmun Neoral,
Sandimmune,
cyclosporin A,
cyclosporine,
Ciclosporin,
59865-13-3,
Cyclosporine A,
Ciclosporine,
Neoral,
Cyclosporin,
Ciclosporina,
Ciclosporinum,
Sandimmune,
Equoral,
Neoplanta,
Sandimmun,
Sang-35,
Gengraf,
Sandimmun Neoral,
UNII-83HN0GTJ6D,
Antibiotic S 7481F1,
Consupren,
Restasis,
Ramihyphin A,
SangCyA,
MFCD00274558,
83HN0GTJ6D,
MLS001333756,
CHEBI:4031,
CSA,
S-Neoral,
Cipol N,
Sigmasporin Microoral,
Sang 35,
DSSTox_CID_365,
Ciclosporine [INN-French],
Ciclosporinum [INN-Latin],
Ciclosporina [INN-Spanish],
Ciclosporin (Ciclosporin A),
DSSTox_RID_75541,
DSSTox_GSID_20365,
SDZ-OXL 400,
OL 27-400,
CCRIS 1590,
HSDB 6881,
Abrammune,
Imusporin,
Seciera,
Vekacia,
DRG-0275,
Papilock Mini,
Arpimune ME,
Zinograf ME,
Sandimmune Neoral,
C62H111N11O12,
NSC 290193,
Ciclosporina Germed,
S 7481F1,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,
CYA,
SMR000058578,
Cicloral (antibiotic),
Debio088,
79217-60-0,
Cyclosporine [USAN:USP],
Sigmasporin,
Cyclokat,
Mitogard,
Papilock,
Pulminiq,
Zyclorin,
CicloMulsion,
CyclosporinA,
Ciclosporin DT,
Consupren S,
NSC290193,
Modusik-A,
NeuroSTAT,
1cyn,
2wfj,
4jjm,
Cipol-N,
NCGC00016890-01,
Neoral, Sandimmune,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methyl-hex-4-enyl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,
(R-(R*,R*-(E)))-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl),
Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl),
Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl),
Cyclo[[(E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl],
Prestwick_731,
Ciclosporin [INN],
CAS-59865-13-3,
CsA & IFN.alpha.,
1c5f,
2z6w,
Prestwick2_000435,
Prestwick3_000435,
CHEMBL160,
Sang-2000,
AC1NR4C4,
SCHEMBL3491,
SCHEMBL4442,
Nova-22007,
Ikervis (opthalmic solution),
BSPBio_000450,
Cyclosporin A & IFN.alpha.,
MLS000028376,
MLS002153454,
MLS002207033,
Verkazia (opthalmic solution),
Cyclosporin-A(Cyclosporine-A),
BPBio1_000496,
GTPL1024,
DTXSID0020365,
CHEBI:92233,
AOB2581,
ATH-002,
OLO-400,
CB-01-09 MMX,
PMATZTZNYRCHOR-CGLBZJNRSA-N,
HMS1569G12,
HMS2089A09,
HMS2096G12,
HMS2230M14,
HMS3713G12,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,
(R-[R*,R*-(E)])-Cyclic(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-3-hydroxy-N,4-dimethyl-L-2-amino-6-octenoyl-L-alpha-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl),
1,11-cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(E)-(2S,3R,4R)-2-amino-3-hydroxy-N,4-dimethyloct-6-enoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine],
30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone,
30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,
30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,
Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl),
Tox21_110667,
Tox21_301849,
BDBM50022815,
DE-076,
ST-603,
Cyclosporin A, >=98.5% (TLC),
AKOS015969287,
Tox21_110667_1,
CCG-208184,
DB00091,
EBD2126862,
KS-1257,
NCGC00093704-12,
NCGC00164258-01,
NCGC00164258-02,
NCGC00164258-03,
NCGC00255232-01,
AT-12519,
C042,
OL-27400,
SBI-0050230.P003,
AB0090560,
5946-EP0930075A1,
5946-EP2289877A1,
5946-EP2292601A1,
5946-EP2292602A1,
5946-EP2292603A1,
5946-EP2292604A2,
5946-EP2292618A1,
5946-EP2293650A1,
5946-EP2298737A1,
5946-EP2298739A1,
5946-EP2298740A1,
5946-EP2298741A1,
5946-EP2298771A2,
5946-EP2301920A1,
5946-EP2301940A1,
5946-EP2308843A1,
5946-EP2308861A1,
J10181,
J90049,
865C133,
Cyclosporin A, VETRANAL(TM), analytical standard,
SR-01000780563,
BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA,
BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA,
Q-200913,
SR-01000780563-3,
BRD-K03222093-001-01-8,
BRD-K13533483-001-03-0,
Ciclosporin, European Pharmacopoeia (EP) Reference Standard,
Cyclosporin A, from Tolypocladium inflatum, >=95% (HPLC), solid,
Cyclosporine, United States Pharmacopeia (USP) Reference Standard,
Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard,
Cyclosporin A, from Tolypocladium inflatum, BioReagent, for molecular biology, >=95%,
Cyclosporine, Pharmaceutical Secondary Standard; Certified Reference Material,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,1,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone,
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecone,
30-Ethyl-33-((E)-1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,28-octamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone,
Cicloral,
Optimmune,
Ciclosporina A,
CsANeoral,
Cyclosporin H,
CsA Neoral,
CsA-Neoral,
Ciclosporine [INN],
CyA NOF,
CyA-NOF,
Cyclosporine [USAN],
Cyclopropylboronic acid,
Cyclosporine A/B/C/D/H,
ACN-029253,
CID5284373,
CS-O-06250,
Ciclosporin (Cyclosporin A; Cyclosporine),
OL 27400,
C62-H111-N11-O12,
OL 27 400,
B1922,
C2408,
A10260,
D016572,
Cyclosporin A, 99%, an immunosuppressive agent - 1G 1g,
,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone,
9,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone,
55126-45-9,